CONMED CORPORATION Acquisitions, Net of Cash Acquired
CONMED CORPORATION (CNMD) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2025-02-18
- CONMED CORPORATION payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- CONMED CORPORATION payments to acquire businesses, net of cash acquired for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- CONMED CORPORATION payments to acquire businesses, net of cash acquired for the quarter ending 2022-12-31 was $642.00K.
- CONMED CORPORATION payments to acquire businesses, net of cash acquired for the quarter ending 2022-09-30 was $84.55M.
- CONMED CORPORATION payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00.
- CONMED CORPORATION payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CONMED CORPORATION payments to acquire businesses, net of cash acquired for fiscal 2022 was $227.74M.
- CONMED CORPORATION payments to acquire businesses, net of cash acquired for fiscal 2021 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $0.00 10-Q · filed 2023-10-26 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-07-27 | |||
| 2022-12-31 | $642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $85.19M derived: sum of 2 quarters · filed 2025-02-18 | $227.74M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $84.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $227.10M 10-Q · filed 2023-10-26 | ||
| 2022-06-30 | $142.56M 10-Q · filed 2023-07-27 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $0.00 10-Q · filed 2022-10-27 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-07-28 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $364.93M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $364.93M 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $364.93M 10-Q · filed 2019-04-26 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-04-26 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-04-27 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $26.00K derived: sum of 2 quarters · filed 2016-10-28 | $256.45M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $256.45M 10-Q · filed 2016-07-28 | ||
| 2016-03-31 | $256.42M 10-Q · filed 2017-04-27 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $5.25M derived: sum of 2 quarters · filed 2016-10-28 | $6.10M 10-Q · filed 2016-10-28 | |
| 2015-06-30 | $5.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $6.10M 10-Q · filed 2016-07-28 | ||
| 2015-03-31 | $853.00K 10-Q · filed 2016-05-02 | |||
| 2014-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-23 | $1.25M derived: sum of 2 quarters · filed 2015-10-23 | $1.25M 10-Q · filed 2015-10-23 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-27 | $0.00 10-Q · filed 2015-07-27 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-04-24 | |||
| 2013-09-30 | $0.00 10-Q · filed 2014-10-24 | |||
| 2011-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $72.00K 10-Q · filed 2011-11-01 | ||
| 2011-06-30 | -$72.00K 10-Q · filed 2011-08-09 | |||
| 2010-09-30 | $10.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $5.23M 10-Q · filed 2011-11-01 | ||
| 2010-06-30 | -$5.16M 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |